Onderneming Northwest Biotherapeutics, Inc. Other OTC
Aandelen
NWBO
US66737P6007
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Immunotherapies for Cancer
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | +14,80% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States, Germany, United Kingdom and Netherlands
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | +14,80% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 17-05-07 |
Alton Boynton
FOU | Founder | 79 | 18-03-96 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-01-00 |
David Innes
IRC | Investor Relations Contact | - | 26-02-19 |
Leslie Goldman
LAW | General Counsel | 78 | 01-06-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 18-03-96 |
Linda Powers
CEO | Chief Executive Officer | 68 | 17-05-07 |
Navid Malik
BRD | Director/Board Member | 55 | 01-04-12 |
Joseph Black
BRD | Director/Board Member | 74 | 27-01-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 300 000 | 0 | 0 | 90,82 % |
Aandeel B | 1 | 1 208 177 416 | 1 097 287 981 ( 90,82 %) | 0 |
Bedrijfsgegevens
Northwest Biotherapeutics, Inc.
4800 Montgomery Lane Suite 800
20814, Bethesda
+240 497 9024
http://www.nwbio.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |